Optimizing the treatment of cervical dysplasia mild to moderate associated with human papilloma virus
The results of the study, which involved 128 women with cervical dysplasia grade 1-2 associated with HPV infection (HPV), which aimed to increase the efficiency of treatment, by including in the complex therapy of such patients immunocorrective drug Vitaferon. Using Vitaferona in treatment of cervical pathology associated with HPV, helped to increase the effectiveness of the therapy to 93.7%.